On May 19, Clarivate Plc (NYSE:CLVT) launched RiskMark, an AI-driven trademark risk evaluation tool combining CompuMark trademark data and Darts-ip litigation records. Using 172.5 million trademark records across 188 jurisdictions and 5 million legal cases, RiskMark employs generative and predictive AI to assess similarity risks, aiding trademark professionals in strategic decision-making and argument drafting.Moderna Inc. (NASDAQ:MRNA) Turns to AI To Enhance Drug Development AFter COVID Vaccine Slowdown

A closeup shot of a laboratory technician handling a medical device used for fertility treatments.

François Neuville, Senior Vice President at Clarivate, stated:

"Trademark professionals are under pressure to make critical decisions when creating and protecting brands. Beyond the administrative elements, it is essential to be able to craft arguments for trademark examiners or for litigation based on precedent and following clear legal principles. Our new tool will enable trademark professionals to do this with speed, ease, and confidence. Thanks to our gold-standard data we can empower IP professionals with trustworthy AI-driven insights to assess risk and accelerate drafting, positioning them for both immediate and long-term success."

Clarivate is a global leader in transformative intelligence, providing data-driven insights, analytics, workflow solutions, and expert services across Academia & Government, Intellectual Property, and Life Sciences & Healthcare.

While we acknowledge the potential of Clarivate Plc (NYSE:CLVT) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CLVT and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None.

View Comments